John Divine

InvestorPlace Assistant Editor

John Divine is currently an investing reporter at U.S. News & World Report, and was previously an assistant editor at InvestorPlace.com. He has worked variously in the fields of commercial real estate, money management and digital media, working as a financial journalist for most of his professional career.

John has also been a regular contributor to The Motley Fool, and his work also has appeared on AOL DailyFinance.

In 2013, he shortened his bucket list when he saw Warren Buffett live and in the flesh while covering the Berkshire Hathaway Annual Shareholders’ Meeting.

A proud North Carolinian and graduate of Appalachian State University, John majored in Finance & Banking. He enjoys basketball, reading, writing and food. He does not care for the Oxford comma, and he does not require the food he enjoys to be nutritious.

Recent Articles

Merck (MRK) Sends Cubist Pharmaceuticals Inc (CBST) Stock Soaring on $9.5 Billion Offer

By John Divine, InvestorPlace Assistant Editor Dec 8, 2014

The healthcare M&A craze of 2014 continues as Merck snaps up Cubist Pharmaceuticals, which has promising drugs in the pipeline and a niche focus.

3 High-Dividend Stocks Perfect for Resurgent Energy Prices

By John Divine, InvestorPlace Assistant Editor Dec 8, 2014

Royalty trusts: These little-talked-about investment vehicles offer extremely high dividends ... but make sure you know the risks up front.

Apple Inc. (AAPL) Stock: Is Push Into India Too Little Too Late?

By John Divine, InvestorPlace Assistant Editor Dec 5, 2014

Apple plans to open 500 retail locations in India, where its market penetration is weak. Unfortunately, that's bad news for long-term shareholders.

Employment News: How the November Jobs Report Crushed Expectations

By John Divine, InvestorPlace Assistant Editor Dec 5, 2014

More good employment news in the U.S., as the November jobs report blows out consensus estimates with gains of 321,000.

Microsoft Cuts Losses, Sells Nook Back to Barnes & Noble (BKS)

By John Divine, InvestorPlace Assistant Editor Dec 4, 2014

The 2012 MSFT Nook investment has been a miserable failure. With more Nook on its books, BKS stock is as hopeless as ever after an earnings miss.

Will Five Star Sale Help Best Buy (BBY) Stock?

By John Divine, InvestorPlace Assistant Editor Dec 4, 2014

The China divestiture is an effort by BBY to focus more intently on North American operations at a pivotal time in the company's history. Will it work?

Abercrombie & Fitch (ANF): 3Q Sales Fall Again, Stock Rallies Anyway

By John Divine, InvestorPlace Assistant Editor Dec 3, 2014

Yet another poor showing by the teen retailer is rewarded with a stellar day on Wall Street. Can you say irrational exuberance?

MOL Global: Why Investors Should Ignore Today’s Pop in MOLG Stock

By John Divine, InvestorPlace Assistant Editor Dec 2, 2014

Do not, under any circumstances, consider riding MOLG stock higher. It has more red flags than a bullfight.

Biogen (BIIB) Stock Spikes on Potential Alzheimer’s Breakthrough

By John Divine, InvestorPlace Assistant Editor Dec 2, 2014

There's no cure for Alzheimer's, which plagues 5 million Americans; BIIB stock is a buy after a promising drug study that could change treatment.

Amazon (AMZN) Ecosystem: The Biggest Threat to AAPL Stock

By John Divine, InvestorPlace Assistant Editor Dec 2, 2014

This AMZN product is high-tech enough for early adopters and practical and cheap enough for the masses. Move over, Apple -- Amazon's ecosystem ain't no joke.